Chapter 9. Future Aspects of Pharmacotherapy in Erectile Dysfunction

  1. Hartmut Porst1,
  2. Jacques Buvat2 and
  3. The Standards Committee of the International Society for Sexual Medicine
  1. Hartmut Porst

Published Online: 11 JAN 2008

DOI: 10.1002/9780470755235.ch9

Standard Practice in Sexual Medicine

Standard Practice in Sexual Medicine

How to Cite

Porst, H. (2006) Future Aspects of Pharmacotherapy in Erectile Dysfunction, in Standard Practice in Sexual Medicine (eds H. Porst, J. Buvat and The Standards Committee of the International Society for Sexual Medicine), Blackwell Publishing Ltd, Oxford, UK. doi: 10.1002/9780470755235.ch9

Editor Information

  1. 1

    Chairman, ISSM Standards Committee, Neuer Jungfernstieg 6a, 20354 Hamburg, Germany

  2. 2

    Co-Chairman, ISSM Standards Committee, Centre ETPARP, 3 Rue Carolus, 59000 Lille, France

Publication History

  1. Published Online: 11 JAN 2008
  2. Published Print: 1 JAN 2006

ISBN Information

Print ISBN: 9781405157193

Online ISBN: 9780470755235

SEARCH

Keywords:

  • erectile function;
  • pharmacotherapy;
  • erectile dysfunction;
  • pharmaceutical industry;
  • clinical investigation;
  • neurotransmitters

Summary

The prelims comprise:

  • Centrally Acting Drugs Under Clinical Investigation

  • Centrally Acting Compounds with the Potential for Pharmacotherapy in ED

  • Peripherally-Acting Drugs Under Clinical Investigation

  • Peripherally-Acting Drugs with the Potential for Pharmacotherapy in ED

  • Conclusions